This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Grifols, S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Nathan Roth: Innovator in Viral Deactivation Techniques
Introduction
Nathan Roth is an accomplished inventor based in Holly Springs, North Carolina. He has made significant contributions to the field of viral deactivation, with a particular focus on methods utilizing caprylate in solutions containing albumin.
Latest Patents
Roth holds one patent titled "Caprylate Viral Deactivation." This patent describes innovative methods for effectively inactivating viruses, highlighting the application of caprylate, which is essential in various biological and medical fields.
Career Highlights
Nathan Roth currently works at Grifols, S.A., a prominent global healthcare company dedicated to improving the quality of life for patients through innovative medicines. His role at Grifols has enabled him to concentrate on developing cutting-edge technologies aimed at enhancing viral safety.
Collaborations
Throughout his career, Nathan has collaborated with fellow professionals including Wytold Lebing and Doug Burns. These partnerships have fostered a collaborative environment that nurtures innovation and advancement in his field.
Conclusion
Nathan Roth exemplifies the spirit of innovation in the healthcare sector, particularly through his patent in viral deactivation. His work continues to have a meaningful impact on safety and effectiveness in viral management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile